Anavex Life Sciences Corp.AVXLNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P7
Near historical low
vs 5Y Ago
-0.8x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -10.15% |
| 2024 | -4.30% |
| 2023 | 15.30% |
| 2022 | 14.95% |
| 2021 | 30.72% |
| 2020 | 13.35% |
| 2019 | 66.81% |
| 2018 | 25.04% |
| 2017 | 47.11% |
| 2016 | 219.33% |